首页> 美国卫生研究院文献>Journal of Virology >Analysis of Adenovirus Sequestration in the Liver Transduction of Hepatic Cells and Innate Toxicity after Injection of Fiber-Modified Vectors
【2h】

Analysis of Adenovirus Sequestration in the Liver Transduction of Hepatic Cells and Innate Toxicity after Injection of Fiber-Modified Vectors

机译:注射纤维修饰载体后肝中腺病毒隔离肝细胞转导和先天毒性的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

After intravenous administration, adenovirus (Ad) vectors are predominantly sequestered by the liver. Delineating the mechanisms for Ad accumulation in the liver is crucial for a better understanding of Ad clearance and Ad-associated innate toxicity. To help address these issues, in this study, we used Ad vectors with different fiber shaft lengths and either coxsackievirus-Ad receptor (CAR)-interacting Ad serotype 9 (Ad9) or non-CAR-interacting Ad35 fiber knob domains. We analyzed the kinetics of Ad vector accumulation in the liver, uptake into hepatocytes and Kupffer cells, and induction of cytokine expression and release in response to systemic vector application. Immediately after intravenous injection, all Ad vectors accumulated equally efficiently in the liver; however, only genomes of long-shafted Ads were maintained in the liver tissue over time. We found that Kupffer cell uptake of long-shafted Ads was mediated by the fiber knob domain and was CAR independent. The short-shafted Ads were unable to efficiently interact with hepatocellular receptors and were not taken up by Kupffer cells. Moreover, our studies indicated that Kupffer cells were not the major reservoir for the observed accumulation of Ads (used in this study) in the liver within the first 30 min after virus infusion. The lower level of liver cell transduction by short-shafted Ads correlated with a significantly reduced inflammatory anti-Ad response as well as liver damage induced by the systemic administration of these vectors. This study contributes to a better understanding of the biology of systemically applied Ad and will help in designing safer vectors that can efficiently transduce target tissues.
机译:静脉内给药后,腺病毒(Ad)载体主要被肝脏隔离。划定肝脏中Ad积累的机制对于更好地了解Ad清除率和与Ad相关的先天毒性至关重要。为了帮助解决这些问题,在这项研究中,我们使用了具有不同纤维轴长度的Ad载体,以及与柯萨奇病毒-Ad受体(CAR)相互作用的Ad血清型9(Ad9)或与非CAR相互作用的Ad35纤维结域。我们分析了Ad载体在肝脏中积累,被肝细胞和Kupffer细胞摄取以及诱导细胞因子表达和释放以响应全身性载体应用的动力学。静脉内注射后,所有Ad载体立即在肝中均等地积累;然而,随着时间的流逝,只有长轴Ads的基因组保留在肝脏组织中。我们发现长轴Ads的Kupffer细胞摄取是由纤维结域介导的,并且与CAR无关。短轴Ads不能与肝细胞受体有效相互作用,也不能被库普弗细胞吸收。此外,我们的研究表明,在输注病毒后的最初30分钟内,Kupffer细胞并不是观察到的Ads积累(本研究中使用的)在肝脏中的主要储存库。短轴Ad引起的肝细胞转导水平较低与炎症性抗Ad反应显着降低以及这些载体的全身性给药引起的肝损害有关。这项研究有助于更好地理解全身应用Ad的生物学特性,并将有助于设计可有效转导靶组织的更安全的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号